Incyte reports promising results from drug that treats skin disease
Incyte announced that data from a late-stage trial the pivotal Phase 3 found ruxolitinib cream was able to lead to add pigment for those suffering from the skin disease vitiligo. T…
More from Delaware Business
Delaware Business Now
Delaware charters pulled for LLC's tied to drug traffickers
Delaware Business
•
Dec 5, 2022
Delmarva Now Business
Rack Room Shoes opens in Salisbury, and a new pool hall on the way | What's Going There
Delaware Business
•
Dec 5, 2022
Delaware Business Now
Suspect dead after carjackings, pursuit by officers in I-95 area
Delaware Business
•
Dec 3, 2022
Delaware Business Now
PBF Energy acquires remaining interests in logistics business
Delaware Business
•
Dec 3, 2022
Delaware Business Now
My take: Feds take closer look at criminal monopoly actions
Delaware Business
•
Dec 3, 2022
Delaware Business Now
ChristianaCare center named in honor of donor and breast cancer survivor Tatiana Copeland
Delaware Business
•
Dec 2, 2022
Delaware State Chamber of Commerce
Veteran Business Leader and Communications Specialist to Assume Role of Vice Chair
Delaware Business
•
Dec 2, 2022